Literature DB >> 11403678

Neurotoxicity of channel mutations in heterologously expressed alpha7-nicotinic acetylcholine receptors.

R J Lukas1, L Lucero, B Buisson, J L Galzi, E Puchacz, J D Fryer, J P Changeux, D Bertrand.   

Abstract

Nicotinic acetylcholine receptors (nAChR) composed of chick alpha7 subunits mutated to threonine at amino acid valine-251 in the putative channel-lining M2 domain were expressed heterologously in several neuron-like and non-neuronal mammalian cell lines. Expression of mutant alpha7-nAChR is toxic to neuron-like cells of the human neuroblastoma cell lines SH-SY5Y and IMR-32, but not to several other cell types. Growth in the presence of the alpha7-nAChR antagonist methyllycaconitine (MLA) protects against neurotoxicity, as does gradual downregulation of functional, mutant alpha7-nAChR in surviving transfected SH-SY5Y cells. Relative to wild-type alpha7-nAChR, functional alpha7-nAChR mutants show a higher affinity for agonists, slower rates of desensitization, and sensitivity to dihydro-beta-erythroidine (DHbetaE) as an agonist, but they retain sensitivity to MLA as a competitive antagonist. These findings demonstrate that expression of hyperfunctional, mutant forms of Ca2+-permeable alpha7-nAChR is toxic to neuron-like cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403678     DOI: 10.1046/j.0953-816x.2001.01560.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

1.  Dendritic Ca2+ signalling due to activation of alpha 7-containing nicotinic acetylcholine receptors in rat hippocampal neurons.

Authors:  Dmitriy Fayuk; Jerrel L Yakel
Journal:  J Physiol       Date:  2007-05-17       Impact factor: 5.182

2.  Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.

Authors:  Herman J Ng; Edward R Whittemore; Minhtam B Tran; Derk J Hogenkamp; Ron S Broide; Timothy B Johnstone; Lijun Zheng; Karen E Stevens; Kelvin W Gee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

3.  A mutation in the extracellular domain of the α7 nAChR reduces calcium permeability.

Authors:  José O Colón-Sáez; Jerrel L Yakel
Journal:  Pflugers Arch       Date:  2013-11-01       Impact factor: 3.657

4.  Boosting Endogenous Resistance of Brain to Ischemia.

Authors:  Fen Sun; Stephen R Johnson; Kunlin Jin; Victor V Uteshev
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

5.  Intrinsically low open probability of α7 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures.

Authors:  Dustin K Williams; Can Peng; Matthew R Kimbrell; Roger L Papke
Journal:  Mol Pharmacol       Date:  2012-07-24       Impact factor: 4.436

Review 6.  Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Biochem Pharmacol       Date:  2011-05-14       Impact factor: 5.858

7.  Bioactivity of a peptide derived from acetylcholinesterase in hippocampal organotypic cultures.

Authors:  T Day; S A Greenfield
Journal:  Exp Brain Res       Date:  2003-12-18       Impact factor: 1.972

8.  Inhibition of native and recombinant nicotinic acetylcholine receptors by the myristoylated alanine-rich C kinase substrate peptide.

Authors:  Elaine A Gay; Rebecca C Klein; Mark A Melton; Perry J Blackshear; Jerrel L Yakel
Journal:  J Pharmacol Exp Ther       Date:  2008-09-23       Impact factor: 4.030

Review 9.  Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells.

Authors:  Silvia Di Angelantonio; Rashid Giniatullin; Valeria Costa; Elena Sokolova; Andrea Nistri
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

10.  A peptide derived from acetylcholinesterase induces neuronal cell death: characterisation of possible mechanisms.

Authors:  T Day; S A Greenfield
Journal:  Exp Brain Res       Date:  2003-09-06       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.